Background: Opioid overdose is a well-established cause of morbidity and mortality in the United States1. Naloxone is an opioid antagonist and harm-reducing treatment with a complex history of prescribing behaviors, attitudes, availability and reimbursement2. Interventions to increase appropriate co-prescription of naloxone include government mandates3 and Electronic Health Record (EHR) clinical decision support4. Our institution used [...]

Background: The opioid crisis remains a threat to public health nationwide. In NYC, there were 3,046 drug overdose deaths in 2023, a decrease of only 1% from 2022, with fentanyl involved in 80% of these fatalities. In 2021, the emergency department at our institution began distributing take-home naloxone kits to at-risk individuals on discharge through [...]